Literature DB >> 27752923

A simple method to induce hypoxia-induced vascular endothelial growth factor-A (VEGF-A) expression in T24 human bladder cancer cells.

Jonas Magno Santos Cesário1, Rodrigo Barbosa Oliveira Brito1, Camila Soares Malta1, Chrisna Souza Silva1, Yves Silva Teles Matos1, Tânia Cristina Macedo Kunz1, Jessica Julioti Urbano2, Luis Vicente Franco Oliveira2, Maria Aparecida Dalboni1, Humberto Dellê3.   

Abstract

Angiogenesis is an essential process for the establishment, development, and dissemination of several malignant tumors including bladder cancer. The hypoxic condition promotes the stabilization of hypoxia-inducible factor 1 alpha (HIF-1α), which translocates to the nucleus to mediate angiogenic factors including the vascular endothelial growth factor A (VEGF-A). AnaeroGen system was developed for microbiology area to create a low oxygen tension required to the growth of anaerobic bacteria. Here, we hypothesized the use of AnaeroGen system to induce hypoxia in T24 human bladder carcinoma cells, in order to promote the overexpression of VEGF-A. T24 cells were cultured in six-well plates containing McCoy medium. Exposures of T24 cells to hypoxia for 1, 8, 24, and 48 h were performed using the Oxoid AnaeroGen system, while T24 cells under normoxia were used as control. The expression of VEGF-A and HIF-1α was analyzed by real-time PCR. ELISA for HIF-1α was carried out. The VEGF-A expression increased significantly by Oxoid AnaeroGen-induced hypoxia in a time-depending manner, reaching the peak in 48 h of hypoxia. Although HIF-1α mRNA was not changed, HIF-1α protein was increased in the presence of hypoxia, reaching a peak at 8 h. These results demonstrated that the Oxoid AnaeroGen system is a simple method to expose T24 cells to hypoxia and efficiently to upregulate VEGF expression in T24 cells.

Entities:  

Keywords:  Angiogenesis; Bladder carcinoma; HIF-1α; Hypoxia; Oxoid AnaeroGen; VEGF-A

Mesh:

Substances:

Year:  2016        PMID: 27752923     DOI: 10.1007/s11626-016-0103-4

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol Anim        ISSN: 1071-2690            Impact factor:   2.416


  20 in total

1.  Expression of HIF-1alpha and Glut-1 in human bladder cancer.

Authors:  V Palit; R M Phillips; R Puri; T Shah; M C Bibby
Journal:  Oncol Rep       Date:  2005-10       Impact factor: 3.906

2.  The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis.

Authors:  P H Maxwell; M S Wiesener; G W Chang; S C Clifford; E C Vaux; M E Cockman; C C Wykoff; C W Pugh; E R Maher; P J Ratcliffe
Journal:  Nature       Date:  1999-05-20       Impact factor: 49.962

3.  Evaluation of AnaeroGen system for growth of anaerobic bacteria.

Authors:  P H Miller; L S Wiggs; J M Miller
Journal:  J Clin Microbiol       Date:  1995-09       Impact factor: 5.948

4.  Vascular endothelial growth factor is a predictor of relapse and stage progression in superficial bladder cancer.

Authors:  J P Crew; T O'Brien; M Bradburn; S Fuggle; R Bicknell; D Cranston; A L Harris
Journal:  Cancer Res       Date:  1997-12-01       Impact factor: 12.701

5.  Cathepsin B is involved in the apoptosis intrinsic pathway induced by Bacillus Calmette-Guérin in transitional cancer cell lines.

Authors:  Eduardo Sandes; Catalina Lodillinsky; Ruth Cwirenbaum; Claudia Argüelles; Alberto Casabé; Ana María Eiján
Journal:  Int J Mol Med       Date:  2007-12       Impact factor: 4.101

6.  RNA interference targeting adrenomedullin induces apoptosis and reduces the growth of human bladder urothelial cell carcinoma.

Authors:  Ai-guang Liu; Xi-zhong Zhang; Fen-bao Li; Yong-li Zhao; Ying-chang Guo; Rui-min Yang
Journal:  Med Oncol       Date:  2013-05-29       Impact factor: 3.064

7.  Lysyl oxidase-like 2 promotes migration in noninvasive breast cancer cells but not in normal breast epithelial cells.

Authors:  Peter Hollosi; Jana K Yakushiji; Keith S K Fong; Katalin Csiszar; Sheri F T Fong
Journal:  Int J Cancer       Date:  2009-07-15       Impact factor: 7.396

8.  Degradation of HIF-1alpha under hypoxia combined with induction of Hsp90 polyubiquitination in cancer cells by hypericin: a unique cancer therapy.

Authors:  Tilda Barliya; Mathilda Mandel; Tami Livnat; Dov Weinberger; Gad Lavie
Journal:  PLoS One       Date:  2011-09-19       Impact factor: 3.240

9.  Sorafenib induces cathepsin B-mediated apoptosis of bladder cancer cells by regulating the Akt/PTEN pathway. The Akt inhibitor, perifosine, enhances the sorafenib-induced cytotoxicity against bladder cancer cells.

Authors:  Consuelo Amantini; Maria Beatrice Morelli; Matteo Santoni; Alessandra Soriani; Claudio Cardinali; Valerio Farfariello; Anna Maria Eleuteri; Laura Bonfili; Matteo Mozzicafreddo; Massimo Nabissi; Stefano Cascinu; Giorgio Santoni
Journal:  Oncoscience       Date:  2015-03-23

10.  Low Molecular Weight Fucoidan Inhibits Tumor Angiogenesis through Downregulation of HIF-1/VEGF Signaling under Hypoxia.

Authors:  Meng-Chuan Chen; Wen-Lin Hsu; Pai-An Hwang; Tz-Chong Chou
Journal:  Mar Drugs       Date:  2015-07-17       Impact factor: 5.118

View more
  2 in total

Review 1.  The Effect of Hypoxia on the Expression of CXC Chemokines and CXC Chemokine Receptors-A Review of Literature.

Authors:  Jan Korbecki; Klaudyna Kojder; Patrycja Kapczuk; Patrycja Kupnicka; Barbara Gawrońska-Szklarz; Izabela Gutowska; Dariusz Chlubek; Irena Baranowska-Bosiacka
Journal:  Int J Mol Sci       Date:  2021-01-15       Impact factor: 5.923

Review 2.  Fractalkine/CX3CL1 in Neoplastic Processes.

Authors:  Jan Korbecki; Donata Simińska; Klaudyna Kojder; Szymon Grochans; Izabela Gutowska; Dariusz Chlubek; Irena Baranowska-Bosiacka
Journal:  Int J Mol Sci       Date:  2020-05-25       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.